Hong Kong HY Pharmaceutical Development Co., Limited
易越科技有限公司
Hong Kong HY Pharmaceutical Development Co., Limited (易越科技有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its Business Registration Number (BRN) is 78778510, classified as a Private company limited by shares. Incorporated on 2025-09-10, the entity has maintained continuous statutory operations for 1 year, currently holding an active legal status of Live. The registered office is situated at RM C20, BLK C, 3/F,, EAST SUN INDUSTRIAL CENTRE,, 16 SHING YIP STREET,, KWUN TONG, HONG KONG. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.
I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 易越科技有限公司 | Official English Name | Hong Kong HY Pharmaceutical Development Co., Limited |
|---|---|---|---|
| Business Reg No. (BRN) | 78778510 | Company Reg No. (CR) | — (No CR Registered) |
| Company Category | Private company limited by shares | Incorporation Date | 2025-09-10 |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-09-10 |
| Registered Office Address |
RM C20, BLK C, 3/F,, EAST SUN INDUSTRIAL CENTRE,, 16 SHING YIP STREET,, KWUN TONG, HONG KONG
|
||
| Significant Controllers (SCR) | Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers. | ||
II. Companies Registry Statutory Image Records
Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.
| Item | Filing Date | Form Ref. | Document Name | Pages | Format | Fee | Action |
|---|---|---|---|---|---|---|---|
| 1 | 2026-09-10 | NAR1 |
NAR1 Statutory Filing
|
17 | ¥28.00 | ||
| 2 | 2025-09-15 | ND2A |
ND2A Statutory Filing
|
4 | ¥28.00 | ||
| 3 | 2025-09-10 | A&A |
A&A Statutory Filing
|
32 | ¥28.00 | ||
| 4 | 2025-09-10 | NNC1 |
NNC1 Statutory Filing
|
22 | ¥28.00 | ||
| 5 | 2025-09-10 | NAR1 |
NAR1 Statutory Filing
|
16 | ¥28.00 |
III. Commercial Due Diligence & Regulatory Risk Screening
Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.
IV. Similar Trade Names & Industry Directory
Hong Kong Heng Ming Mold …
香港衡鸣模具有限公司
JIN NAN INTERNATIONAL LIM…
锦南国际有限公司
SINOUNION INTERNATIONAL I…
中联国际工贸有限公司
CHINA PRECISION MAGNETS &…
深圳朝阳精密磁性材料有限公司
JWENRICH CONSULTING LIMIT…
HONGKONG YELLOW RIVER INT…
香港黄河国际有限公司